Trino Therapeutics Overview
- Year Founded
-
1999
- Status
-
Out of Business
- Employees
-
4
- Latest Deal Type
-
Liquidation
Trino Therapeutics General Information
Description
Manufacturer of pharmaceuticals intended for the treatment and unmet management of inflammatory bowel disease (IBD) and other inflammatory indications. The company's pharmaceuticals focuses on drug discovery helps clients in dermatology, pulmonary and auto-immune diseases.
Contact Information
Website
www.trinotherapeutics.com
Formerly Known As
Pharmatrin
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Pharmaceuticals
Primary Office
- The Tower
- Trinity Technology and Enterprise, Pearse Street Campus, Pearse Street
- Dublin 2
- Ireland
+353 (01) 000 0000
Trino Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Bankruptcy: Liquidation | 01-Sep-2016 | 000.00 | Completed | Bankruptcy: Liquidation | ||
| 2. Early Stage VC (Series A) | 28-May-2013 | 000.00 | 000.00 | Completed | Generating Revenue | |
| 1. Early Stage VC | Completed | Generating Revenue |
Trino Therapeutics Executive Team (5)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Geoffrey Kitson MD | Consultant Chief Medical Officer |
Trino Therapeutics Board Members (7)
| Name | Representing | Role | Since |
|---|---|---|---|
| Marie Lindner | Trino Therapeutics | Board Member | 000 0000 |
| Piers Morgan Ph.D | Self | Chairman | 000 0000 |
Trino Therapeutics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
